The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
暂无分享,去创建一个
Bernard Rosner | D. Singer | B. Rosner | D. Gress | M. Sheehan | J. Kistler | Daniel E Singer | Robert A Hughes | Daryl R Gress | Mary A Sheehan | Lynn B Oertel | Sue Ward Maraventano | Dyan Ryan Blewett | J Philip Kistler | R. Hughes | L. Oertel | D. Blewett | S. W. Maraventano | Mary A. Sheehan
[1] H. Morgenstern,et al. Epidemiologic Research: Principles and Quantitative Methods. , 1983 .
[2] C. Nair,et al. Long-term follow-up of patients with echocardiographically detected mitral anular calcium and comparison with age- and sex-matched control subjects. , 1989, The American journal of cardiology.
[3] T. Chalmers,et al. Meta-analyses of randomized controlled trials. , 1987, The New England journal of medicine.
[4] P. Stevenson,et al. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. , 1990, The New England journal of medicine.
[5] J. Schlesselman,et al. Case-Control Studies: Design, Conduct, Analysis , 1982 .
[6] P. Wolf,et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke , 1978, Neurology.
[7] Palle Petersen,et al. PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.
[8] V. Fuster,et al. Atrial fibrillation--risk marker for stroke. , 1990, The New England journal of medicine.
[9] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[10] A. Gallus,et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. , 1990, The New England journal of medicine.
[11] B. Gersh,et al. The natural history of lone atrial fibrillation. A population-based study over three decades. , 1987, The New England journal of medicine.
[12] K. Bauer,et al. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. , 1987, The Journal of clinical investigation.
[13] J. Hirsh,et al. Optimal therapeutic range for oral anticoagulants. , 1989, Chest.
[14] L. Poller,et al. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. , 1987, British medical journal.
[15] F. Verheugt,et al. Effect of low dose acetylsalicylic acid on the frequency and hematologic activity of left ventricular thrombus in anterior wall acute myocardial infarction. , 1989, The American journal of cardiology.
[16] S. Pocock,et al. Stopping rules and estimation problems in clinical trials. , 1988, Statistics in medicine.
[17] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[18] V. Fuster,et al. Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk. , 1989, Circulation.
[19] W. Aronow,et al. Association of mitral anular calcium with new thromboembolic stroke and cardiac events at 39-month follow-up in elderly patients. , 1990, The American journal of cardiology.
[20] W. Roberts,et al. Morphologic features of the normal and abnormal mitral valve. , 1983, The American journal of cardiology.
[21] J. Fallon,et al. Influence of etiology of atrial fibrillation on incidence of systemic embolism. , 1977, The American journal of cardiology.
[22] A. Weyman. Cross-sectional echocardiography , 1982 .
[23] M. Verstraete,et al. Questions and Answers on Prothrombin Time Standardisation in Oral Anticoagulant Control , 1985, Thrombosis and Haemostasis.
[24] Frank J. Hildner,et al. ArticlesAntithrombotic Therapy in Atrial Fibrillation , 1989 .
[25] G. Raskob,et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. , 1982, The New England journal of medicine.
[26] M. Britton,et al. Non-rheumatic atrial fibrillation as a risk factor for stroke. , 1985, Stroke.
[27] P. Cooper. What will reorganisation do for the patient , 1974 .